Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Hold
658
0.02% 434
2026
Q1
$232K Hold
658
0.02% 421
2025
Q4
$215K Sell
658
-66
-9% -$20.9K 0.02% 409
2025
Q3
$204K Buy
+724
New +$210K 0.02% 381
2022
Q3
Sell
-848
Closed -$206K 313
2022
Q2
$206K Buy
+848
New +$208K 0.03% 285
2019
Q1
Sell
-1,788
Closed -$348K 207
2018
Q4
$348K Sell
1,788
-46
-3% -$8.97K 0.06% 141
2018
Q3
$380K Buy
1,834
+13
+0.7% +$2.56K 0.07% 144
2018
Q2
$336K Hold
1,821
0.06% 145
2018
Q1
$310K Hold
1,821
0.06% 146
2017
Q4
$317K Hold
1,821
0.06% 147
2017
Q3
$340K Sell
1,821
-100
-5% -$17.7K 0.06% 140
2017
Q2
$331K Buy
1,921
+46
+2% +$7.48K 0.05% 136
2017
Q1
$308K Buy
+1,875
New +$312K 0.06% 140
2015
Q1
Sell
-10,223
Closed -$1.63M 156
2014
Q4
$1.63M Buy
+10,223
New +$1.59M 0.24% 85

Other funds holding AMGN

Pekin Hardy Strauss's AMGN Position: Q2 2026 in Review

Pekin Hardy Strauss held its Amgen (AMGN) position steady in Q2 2026 at 658 shares worth $238K. The position accounts for 0.02% of the portfolio, ranked #434.

Pekin Hardy Strauss first reported a position in AMGN in Q4 2014 and has held it in 14 quarters since. The position peaked at $1.63M in Q4 2014. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Pekin Hardy Strauss held 658 shares of Amgen worth $238K as of Q2 2026.
  • Pekin Hardy Strauss left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.02% of Pekin Hardy Strauss's portfolio in Q2 2026, its #434 holding.
  • Pekin Hardy Strauss first reported a position in Amgen in Q4 2014 and has held it in 14 quarters since.
  • Pekin Hardy Strauss's Amgen position peaked at $1.63M in Q4 2014.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Pekin Hardy Strauss's 13F filing for Q2 2026, filed 30 Jul 2026.